Medpace Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring at the 2026 Annual Meeting of Stockholders held on May 15, 2026. The filing details the approval of corporate governance amendments and the results of stockholder votes on director elections, auditor ratification, and executive compensation.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results rather than financial performance.
Material Changes and Governance Amendments
Stockholders approved two significant amendments to the Restated Certificate of Incorporation, effective May 18, 2026:
- Removal of supermajority voting requirements.
- Removal of limitations on stockholders calling special meetings.
Concurrently, the Board approved amendments to the Bylaws to allow stockholders owning at least 25% of the voting power (held continuously for one year) to call special meetings.
Voting Results and Management Commentary
Director Elections: All nominees were elected to the Board of Directors.
- Brian T. Carley: 22,251,529 votes For.
- Femida H. Gwadry-Sridhar: 23,736,619 votes For.
- Robert O. Kraft: 22,148,880 votes For.
- August J. Troendle: 23,900,589 votes For.
- Dani S. Zander: 23,721,072 votes For.
Other Proposals:
- Auditor Ratification: Deloitte & Touche LLP was ratified (25,269,569 For).
- Executive Compensation (Say-on-Pay): Approved (22,656,335 For).
- Compensation Vote Frequency: Stockholders voted for annual advisory votes (23,989,262 For).
- Stockholder Proposal: A non-binding proposal regarding the ability to call special meetings was defeated (8,306,071 For vs. 16,081,493 Against).
Key Facts for Investor Verification
- Verify the effective date of the Certificate of Incorporation amendments (May 18, 2026) and the specific language in the Restated Certificate (Exhibit 3.1).
- Confirm the new threshold and holding period requirements for stockholders to call special meetings under the Third Amended and Restated Bylaws (Exhibit 3.2).
- Note that the Board has committed to annual advisory votes on executive compensation based on the May 15, 2026 results.
- Review the significant opposition to the stockholder proposal (Proposal 7) regarding special meeting rights, which contrasts with the approved management proposal (Proposal 6) on the same topic.